Silence Therapeutics (SLN) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Silence Therapeutics (SLN) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Silence Therapeutics

· SLN

Dashboard

Financials

Ratios

Valuation

Statistics

671.264 M

+1.20%

General

Market Cap: $671.26M
Enterprise Value: $444.33M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 51.00%
Operating Margin: -10880.25%
Net Profit Margin: -9759.23%
FCF Margin: -6893.22%
ROA: -56.34%
ROE: -106.94%
ROIC: -71.25%
Current Ratio: 7.42
Debt-to-Equity: 0.00
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: —
EV/EBITDA: -7.37

Growth

Rev 1Y: -98.71%
Rev 1Y Fwd Est: -21.62%
Rev 3Y (CAGR): -68.36%
Rev 5Y (CAGR): -36.65%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: $614.29K
Gross Margin: 51.00%
Operating Expenses: $67.15M
Operating Income: -$66.84M
Net Profit: -$59.95M

Balance Sheet

Cash and Equivalents: $72.05M
Working Capital: $81.57M
Total Assets: $106.41M
Net Debt: -$71.94M
Total Liabilities: $67.94M
Total Equity: $38.47M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$42.29M
Cash Flow from Investing: $72.89M
Cash Flow from Financing: $1.91K
Free Cash Flow: -$42.34M
Capital Expenditures: $58K